Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Union of pediatricians of Russia
2020-08-01
|
| Col·lecció: | Педиатрическая фармакология |
| Matèries: | |
| Accés en línia: | https://www.pedpharma.ru/jour/article/view/1858 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|